Registry for patients with uneven emphysema lung damage
Part of Lungs & breathing clinical trials.
This study follows people with uneven emphysema to better understand outcomes and safety after treatment. If you qualify, you’ll share health information and may undergo lung imaging before and after treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re at least 18 years old
- Your CT lung scan shows uneven emphysema in at least one area (a “heterogeneity index” ≥ 1.2)
- You can and will sign an informed consent form
- Your lung function is not extremely low (FEV1 ≥ 20% and DLCO ≥ 20% of predicted)
- You can walk more than 140 meters in 6 minutes after the best available medical treatment
- You do not currently have major COPD instability or recent severe flare-ups
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a procedure called Endobronchial Thermal Liquid Ablation (ETLA) that uses heated liquid to treat severe emphysema. It is for people with COPD who have very low lung function and shortness of breath, and who have not been able to get relief from other treatments.
This study looks at a procedure to “complete” a lung fissure in people whose prior bronchoscopic lung volume reduction did not work as well as hoped. It may help reduce persistent shortness of breath, but eligibility depends on your lung test results and overall heart/lung safety.
This trial tests a one-way lung valve system to reduce over-inflated lung areas in people with emphysema. It’s aimed at patients whose lung scans suggest they may benefit from “fissure completion” to improve airflow.
This trial tests a new treatment called AeriSeal to seal off damaged parts of the lung in people with severe emphysema. It aims to help you breathe better by reducing the amount of air trapped in your lungs.
This trial tests a new implant for people with severe emphysema. It aims to see if the implant can help you breathe easier and walk farther.
This study tests a minimally invasive “vapor ablation” procedure that destroys small lung cancer spots. It may be an option if you were recommended surgery or an alternative to surgery instead.
Hear when a new Emphysema or COPD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.